Gavi Welcomes Restoration of US Funding – But No Clarity on How Agency will Phase out Thimerosal
The United States has unlocked frozen Gavi funding, resolving a bitter political impasse in Washington while doubling down against the WHO. But can the alliance eliminate thimerosal, a mercury-containing preservative, from its stockpiles without leaving millions of vulnerable children unprotected? The United States will immediately release $600 million for fiscal years 2025–2026 in frozen Gavi […]
We haven't written up this one. Health Policy Watch has the full story — the link below goes straight to it.
